Collaboration For Prevention And Treatment Of Mdr Bacterial Infections

  Address - Sweden

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 10333146

  Document Type - Tender Notices

Description - Grant agreement ID: 853967Start date 1 November 2019End date 31 October 2025Overall budget € 25 460 100 ObjectiveThe loss of antibiotic effectiveness due to increasing antimicrobial resistance (AMR) is a serious threat to global public health. The IMI2 AMR Accelerator will develop new agents to treat and prevent infections caused by MDR and XDR bacteria, including Mycobacterium tuberculosis and non-tuberculous mycobacteria. The COMBINE proposal addresses Pillar A, the Capability Building Network (CBN) of the AMR Accelerator programme. The COMBINE consortium will form a Coordination and Support Office (CSO) that will support the delivery of projects across the AMR Accelerator, as well as wi

Mt Ref Id - 10333146

Deadline - Oct 31, 2025